請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74891
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘敏雄 | |
dc.contributor.author | KUN-FENG HSIEH | en |
dc.contributor.author | 謝昆峰 | zh_TW |
dc.date.accessioned | 2021-06-17T09:09:40Z | - |
dc.date.available | 2020-10-16 | |
dc.date.copyright | 2019-10-16 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-10-09 | |
dc.identifier.citation | Abbas, S.; Wink, M. Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2/insulin-like signaling pathway. Phytomedicine 2010, 17, 902-909.
Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J. I.; Van Nostrand, W. E.; Smith, S. O. Structural conversion of neurotoxic amyloid-β 1-42 oligomers to fibrils. Nature Structural and Molecular Biology 2010, 17, 561-567. Arafa, E. S. A.; Zhu, Q.; Barakat, B. M.; Wani, G.; Zhao, Q.; El-Mahdy, M. A.; Wani, A. A. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Research 2009, 69, 8910-8917. Arendash, G.; Schleif, W.; Rezai-Zadeh, K.; Jackson, E.; Zacharia, L.; Cracchiolo, J.; Shippy, D.; Tan, J. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 2006, 142, 941-952. Armstrong, R. A.; Winsper, S.; Blair, J., Aluminium and Alzheimer's disease: review of possible pathogenic mechanisms. Dementia and Geriatric Cognitive Disorders 1996, 7, 1-9. Armstrong, R. A.; Cairns, N. J.; Lantos, P. L. What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 2001, 21, 1-12. Armstrong, R. A. Plaques and tangles and the pathogenesis of Alzheimer’s disease. Folia Neuropathologica 2006, 44, 1-11. Armstrong, R. A. What causes Alzheimer’s disease? Folia Neuropathologica 2013, 51, 169-188. Association, A. s. 2013 Alzheimer's disease facts and figures. Alzheimer's & dementia 2013, 9, 208-245. Augustinack, J. C.; Schneider, A.; Mandelkow, E. M.; Hyman, B. T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathologica 2002, 103, 26-35. Berlett, B. S.; Stadtman, E. R. Protein oxidation in aging, disease, and oxidative stress. Journal of Biological Chemistry 1997, 272, 20313-20316. Brown, M. K.; Evans, J. L.; Luo, Y. Beneficial effects of natural antioxidants EGCG and α-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans. Pharmacology Biochemistry and Behavior 2006, 85, 620-628. Butterfield, D. A.; Lauderback, C. M. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radical Biology and Medicine 2002, 32, 1050-1060. Butterfield, D. A.; Boyd-Kimball, D. The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 2005, 1703, 149-156. Butterfield, D. A.; Galvan, V.; Lange, M. B.; Tang, H.; Sowell, R. A.; Spilman, P.; Fombonne, J.; Gorostiza, O.; Zhang, J.; Sultana, R. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid β-peptide of APP. Free Radical Biology and Medicine 2010, 48, 136-144. Butterfield, D. A.; Swomley, A. M.; Sultana, R. Amyloid beta-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal 2013, 19, 823-35. Charoensinphon, N.; Qiu, P.; Dong, P.; Zheng, J.; Ngauv, P.; Cao, Y.; Li, S.; Ho, C. T.; Xiao, H. 5-demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis. Molecular Nutrition and Food Research 2013, 57, 2103-11. Cho, J. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Archives of Pharmacal Research 2006, 29, 699-706. Christen, Y. Oxidative stress and Alzheimer disease. The American Journal of Clinical Nutrition 2000, 71, 621s-629s. Chun, O. K.; Chung, S. J.; Song, W. O. Estimated dietary flavonoid intake and major food sources of US adults. The Journal of nutrition 2007, 137, 1244-1252. Cohen, E.; Bieschke, J.; Perciavalle, R. M.; Kelly, J. W.; Dillin, A. Opposing activities protect against age-onset proteotoxicity. Science 2006, 313, 1604-1610. Datla, K. P.; Christidou, M.; Widmer, W. W.; Rooprai, H. K.; Dexter, D. T. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 2001, 12, 3871-3875. de Castro, E.; de Castro, S. H.; Johnson, T. E. Isolation of long-lived mutants in Caenorhabditis elegans using selection for resistance to juglone. Free Radical Biology and Medicine 2004, 37, 139-145. Depuydt, G.; Vanfleteren, J. R.; Braeckman, B. P. Protein metabolism and lifespan in Caenorhabditis elegans. Protein Metabolism and Homeostasis in Aging 2010; pp 81-107. Diomede, L.; Cassata, G.; Fiordaliso, F.; Salio, M.; Ami, D.; Natalello, A.; Doglia, S. M.; De Luigi, A.; Salmona, M. Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers. Neurobiology of Disease 2010, 40, 424-431. Dostal, V.; Link, C. D. Assaying beta-amyloid toxicity using a transgenic C. elegans model. Journal of Visualized Experiments 2010. 44, 2252 Dostal, V.; Roberts, C. M.; Link, C. D. Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of beta-amyloid peptide toxicity. Genetics 2010, 186, 857-66. Drake, J.; Link, C. D.; Butterfield, D. A. Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model. Neurobiology of Aging 2003, 24, 415-420. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation 2004, 114, 1752. Glauser, D. A.; Schlegel, W. The emerging role of FOXO transcription factors in pancreatic β cells. Journal of Endocrinology 2007, 193, 195-207. Good, P. F.; Werner, P.; Hsu, A.; Olanow, C. W.; Perl, D. P. Evidence of neuronal oxidative damage in Alzheimer's disease. The American Journal of Pathology 1996, 149, 21. Guarente, L.; Kenyon, C. Genetic pathways that regulate ageing in model organisms. Nature 2000, 408, 255-262. Haass, C.; Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nature reviews Molecular Cell Biology 2007, 8, 101-112. Hebert, L. E.; Weuve, J.; Scherr, P. A.; Evans, D. A. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 2013, 80, 1778-1783. Heidler, T.; Hartwig, K.; Daniel, H.; Wenzel, U. Caenorhabditis elegans lifespan extension caused by treatment with an orally active ROS-generator is dependent on DAF-16 and SIR-2.1. Biogerontology 2010, 11, 183-195. Henderson, S. T.; Johnson, T. E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Current Biology 2001, 11, 1975-1980. Honda, Y.; Honda, S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. The FASEB Journal 1999, 13, 1385-1393. Honda, Y.; Honda, S. Oxidative stress and life span determination in the nematode Caenorhabditis elegans. Annals of the New York Academy of Sciences 2002, 959, 466-474. Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C. Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science 1996, 274, 98. Hsu, A. L.; Murphy, C. T.; Kenyon, C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003, 300, 1142-1145. Huang, Y. S.; Ho, S. C. Polymethoxy flavones are responsible for the anti-inflammatory activity of citrus fruit peel. Food Chemistry 2010, 119, 868-873. Hwang, S. L.; Shih, P. H.; Yen, G.-C. Neuroprotective effects of citrus flavonoids. Journal of Agricultural and Food Chemistry 2012, 60, 877-885. Imhof, A.; Kövari, E.; von Gunten, A.; Gold, G.; Rivara, C.-B.; Herrmann, F. R.; Hof, P. R.; Bouras, C.; Giannakopoulos, P. Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? Journal of the Neurological Sciences 2007, 257, 72-79. Iqbal, K.; Alonso, A. D. C.; Chen, S.; Chohan, M. O.; El Akkad, E.; Gong, C. X.; Khatoon, S.; Li, B.; Liu, F.; Rahman, A. Tau pathology in Alzheimer disease and other tauopathies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 2005, 1739, 198-210. Irvine, G. B.; El Agnaf, O. M.; Shankar, G. M.; Walsh, D. M. Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Molecular Medicine Camberidge Ma Then New York 2008, 14, 451. Jiang, F.; Dusting, G. J. Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Current vascular pharmacology 2003, 1, 135-156. Joseph, J. A.; Bielinski, D. F.; Fisher, D. R. Blueberry treatment antagonizes C-2 ceramide-induced stress signaling in muscarinic receptor-transfected COS-7 cells. Journal of Agricultural and Food Chemistry 2010, 58, 3380-3392. Kampkötter, A.; Gombitang Nkwonkam, C.; Zurawski, R. F.; Timpel, C.; Chovolou, Y.; Wätjen, W.; Kahl, R. Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans. Archives of Toxicology 2007a, 81, 849-858. Kampkötter, A.; Nkwonkam, C. G.; Zurawski, R. F.; Timpel, C.; Chovolou, Y.; Wätjen, W.; Kahl, R. Investigations of protective effects of the flavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 2007b, 234, 113-123. Kampkötter, A.; Timpel, C.; Zurawski, R. F.; Ruhl, S.; Chovolou, Y.; Proksch, P.; Wätjen, W. Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2008, 149, 314-323. Keowkase, R.; Aboukhatwa, M.; Luo, Y. Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans. Neuropharmacology 2010, 59, 358-365. Khachaturian, Z. S. Diagnosis of Alzheimer's disease. Archives of Neurology 1985, 42, 1097-1105. Khlistunova, I.; Biernat, J.; Wang, Y.; Pickhardt, M.; von Bergen, M.; Gazova, Z.; Mandelkow, E.; Mandelkow, E. M. Inducible expression of Tau repeat domain in cell models of tauopathy aggregation is toxic to cells but can be reversed by inhibitor drugs. Journal of Biological Chemistry 2006, 281, 1205-1214. Kikis, E. A., The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease. Biology Direct 2016, 11, 58. Kim, J. K.; Choi, S. J.; Cho, H. Y.; Hwang, H. J.; Kim, Y. J.; Lim, S. T.; Kim, C. J.; Kim, H. K.; Peterson, S.; Shin, D. H. Protective effects of kaempferol (3, 4', 5, 7-tetrahydroxyflavone) against amyloid beta peptide (A)-induced neurotoxicity in ICR mice. Bioscience, Biotechnology, and Biochemistry 2010, 74, 397-401. Kim, M. S.; Hur, H. J.; Kwon, D. Y.; Hwang, J. T., Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice. Molecular and Cellular Endocrinology 2012, 358, 127-134. Kimura, K. D.; Tissenbaum, H. A.; Liu, Y.; Ruvkun, G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277, 942-946. Labuschagne, C. F.; Brenkman, A. B. Current methods in quantifying ROS and oxidative damage in Caenorhabditis elegans and other model organism of aging. Ageing Research Reviews 2013, 12, 918-930. Lai, C. S.; Tsai, M. L.; Cheng, A. C.; Li, S.; Lo, C. Y.; Wang, Y.; Xiao, H.; Ho, C. T.; Wang, Y. J.; Pan, M. H. Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane‐treated mice. Molecular Nutrition & Food Research 2011, 55, 278-290. Lai, C. S.; Ho, M. H.; Tsai, M. L.; Li, S.; Badmaev, V.; Ho, C. T.; Pan, M. H., Suppression of adipogenesis and obesity in high-fat induced mouse model by hydroxylated polymethoxyflavones. Journal of Agricultural and Food Chemistry 2013, 61, 10320-8. Lakshmi, A.; Subramanian, S. P. Tangeretin ameliorates oxidative stress in the renal tissues of rats with experimental breast cancer induced by 7, 12-dimethylbenz [a] anthracene. Toxicology Letters 2014, 229, 333-348. Lapierre, L. R.; Hansen, M. Lessons from C. elegans: signaling pathways for longevity. Trends in Endocrinology & Metabolism 2012, 23, 637-644. Lee, J. W.; Lee, Y. K.; Ban, J. O.; Ha, T. Y.; Yun, Y. P.; Han, S. B.; Oh, K. W.; Hong, J. T. Green tea (-)-epigallocatechin-3-gallate inhibits β-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-κB pathways in mice. The Journal of Nutrition 2009, 139, 1987-1993. Lee, V. M.; Goedert, M.; Trojanowski, J. Q. Neurodegenerative tauopathies. Annual Review of Neuroscience 2001, 24, 1121-1159. Lee, Y. S.; Cha, B. Y.; Choi, S. S.; Choi, B. K.; Yonezawa, T.; Teruya, T.; Nagai, K.; Woo, J. T. Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice. The Journal of Nutritional Biochemistry 2013, 24, 156-162. Lin, M. T.; Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443, 787-795. Link, C. D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proceedings of the National Academy of Sciences 1995, 92, 9368-9372. Link, C. D.; Taft, A.; Kapulkin, V.; Duke, K.; Kim, S.; Fei, Q.; Wood, D. E.; Sahagan, B. G. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer’s disease model. Neurobiology of Aging 2003, 24, 397-413. Liu, R.; Meng, F.; Zhang, L.; Liu, A.; Qin, H.; Lan, X.; Li, L.; Du, G., Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in β-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Molecules 2011, 16, 2084-2096. Lublin, A.; Link, C. Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity. Drug Discovery Today: Technologies 2013, 10, 115-119. Maddux, B. A.; See, W.; Lawrence, J. C.; Goldfine, A. L.; Goldfine, I. D.; Evans, J. L. Protection Against Oxidative Stress—Induced Insulin Resistance in Rat L6 Muscle Cells by Micromolar Concentrations of α-Lipoic Acid. Diabetes 2001, 50, 404-410. Marambaud, P.; Zhao, H.; Davies, P. Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides. Journal of Biological Chemistry 2005, 280, 37377-37382. Markesbery, W. R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology and Medicine 1997, 23, 134-147. Mayeux, R.; Tang, M. X.; Jacobs, D. M.; Manly, J.; Bell, K.; Merchant, C.; Small, S. A.; Stern, Y.; Wisniewski, H. M.; Mehta, P. D. Plasma amyloid β‐peptide 1–42 and incipient Alzheimer's disease. Annals of Neurology 1999, 46, 412-416. Mehta, D.; Jackson, R.; Paul, G.; Shi, J.; Sabbagh, M. Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015. Expert Opinion on Investigational Drugs 2017, 735-739. Minniti, A. N.; Arrazola, M. S.; Bravo-Zehnder, M.; Ramos, F.; Inestrosa, N. C.; Aldunate, R. The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Abeta aggregation and toxicity in vivo. Antioxidants & Redox Signaling 2015, 22, 48-62. Morley, K. L.; Ferguson, P. J.; Koropatnick, J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Letters 2007, 251, 168-178. Mulvihill, E. E.; Burke, A. C.; Huff, M. W. Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. Annual Review of Nutrition 2016, 36, 275-99. Mungarro‐Menchaca, X.; Ferrera, P.; Morán, J.; Arias, C. β‐Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. Journal of Neuroscience Research 2002, 68, 89-96. Murphy, C. T.; Hu, P. J. Insulin/insulin-like growth factor signaling in C. elegans. 2005. Nikolaev, A.; McLaughlin, T.; O’Leary, D. D.; Tessier-Lavigne, M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457, 981-989. O'Rourke, E. J.; Soukas, A. A.; Carr, C. E.; Ruvkun, G. C. elegans major fats are stored in vesicles distinct from lysosome-related organelles. Cell Metabolism 2009, 10, 430-435. Obregon, D. F.; Rezai-Zadeh, K.; Bai, Y.; Sun, N.; Hou, H.; Ehrhart, J.; Zeng, J.; Mori, T.; Arendash, G. W.; Shytle, D. ADAM10 activation is required for green tea (–)-epigallocatechin-3-gallate-induced α-secretase cleavage of amyloid precursor protein. Journal of Biological Chemistry 2006, 281, 16419-16427. Oddo, S.; Vasilevko, V.; Caccamo, A.; Kitazawa, M.; Cribbs, D. H.; LaFerla, F. M. Reduction of soluble Aβ and tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. Journal of Biological Chemistry 2006, 281, 39413-39423. Ogg, S.; Paradis, S.; Gottlieb, S.; Patterson, G. I.; Lee, L.; Tissenbaum, H. A.; Ruvkun, G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997, 389, 994-999. Onda, K.; Horike, N.; Suzuki, T. i.; Hirano, T., Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytes. Phytotherapy Research 2013, 27, 312-316. Ono, K.; Condron, M. M.; Ho, L.; Wang, J.; Zhao, W.; Pasinetti, G. M.; Teplow, D. B. Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity. Journal of Biological Chemistry 2008, 283, 32176-32187. Onozuka, H.; Nakajima, A.; Matsuzaki, K.; Shin, R.-W.; Ogino, K.; Saigusa, D.; Tetsu, N.; Yokosuka, A.; Sashida, Y.; Mimaki, Y. Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 2008, 326, 739-744. Pappolla, M.; Chyan, Y.; Omar, t. R.; Hsiao, K.; Perry, G.; Smith, M.; Bozner, P. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. The American Journal of Pathology 1998, 152, 871. Periyasamy, K.; Baskaran, K.; Ilakkia, A.; Vanitha, K.; Selvaraj, S.; Sakthisekaran, D. Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7, 12-dimethylbenz (a) anthracene-induced proliferative breast cancer in Sprague–Dawley rats. Cancer Chemotherapy and Pharmacology 2015, 75, 263-272. Porta-de-la-Riva, M.; Fontrodona, L.; Villanueva, A.; Ceron, J. Basic Caenorhabditis elegans methods: synchronization and observation. J Vis Exp 2012, e4019. Querfurth, H. W.; LaFerla, F. M. Alzheimer's Disease. New England Journal of Medicine 2010, 362, 329-344. Regitz, C.; Marie Dußling, L.; Wenzel, U. Amyloid‐beta (Aβ1–42)‐induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways. Molecular Nutrition and Food Research 2014, 58, 1931-1940. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Biology and Medicine 2010, 49, 1603-1616. Rezai-Zadeh, K.; Arendash, G. W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R. D.; Tan, J. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Research 2008, 1214, 177-187. Rodriguez, M.; Snoek, L. B.; De Bono, M.; Kammenga, J. E. Worms under stress: C. elegans stress response and its relevance to complex human disease and aging. Trends in Genetics 2013, 29, 367-374. Ross, C. A.; Poirier, M. A. Protein aggregation and neurodegenerative disease. Nature Medicine 2004, 10, 10-17. Santacruz, K.; Lewis, J.; Spires, T.; Paulson, J.; Kotilinek, L.; Ingelsson, M.; Guimaraes, A.; Deture, M.; Ramsden, M.; McGowan, E. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309, 476-481. Sato, T.; Koike, L.; Miyata, Y.; Hirata, M.; Mimaki, Y.; Sashida, Y.; Yano, M.; Ito, A. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and-9 in human fibrosarcoma HT-1080 cells. Cancer Research 2002, 62, 1025-1029. Shi, Y. C.; Liao, V. H. C.; Pan, T. M. Monascin from red mold dioscorea as a novel antidiabetic and antioxidative stress agent in rats and Caenorhabditis elegans. Free Radical Biology and Medicine 2012, 52, 109-117. Shi, Y. C.; Pan, T. M.; Liao, V. H. C. Monascin from monascus-fermented products eeduces oxidative stress and amyloid-β toxicity via DAF-16/FOXO in Caenorhabditis elegans. Journal of Agricultural and Food Chemistry 2016, 64, 7114-7120. Strittmatter, W. J.; Weisgraber, K. H.; Huang, D. Y.; Dong, L.-M.; Salvesen, G. S.; Pericak-Vance, M.; Schmechel, D.; Saunders, A. M.; Goldgaber, D.; Roses, A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences 1993, 90, 8098-8102. Sun, Y.; Qiao, L.; Shen, Y.; Jiang, P.; Chen, J.; Ye, X. Phytochemical profile and antioxidant activity of physiological drop of citrus fruits. Journal of Food Science 2013, 78, C37-42. Valko, M.; Rhodes, C.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006, 160, 1-40. Varadarajan, S.; Kanski, J.; Aksenova, M.; Lauderback, C.; Butterfield, D. A. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer‘s Aβ (1-42) and Aβ (25-35). Journal of the American Chemical Society 2001, 123, 5625-5631. Vassar, R.; Bennett, B. D.; Babu-Khan, S.; Kahn, S.; Mendiaz, E. A.; Denis, P.; Teplow, D. B.; Ross, S.; Amarante, P.; Loeloff, R. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286, 735-741. Vingtdeux, V.; Dreses-Werringloer, U.; Zhao, H.; Davies, P.; Marambaud, P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neuroscience 2008, 9, S6. Walsh, D.; Klyubin, I.; Fadeeva, J.; Rowan, M.; Selkoe, D. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition. Biochemical Society Transactions 2002, 552-557. Wan, L.; Nie, G.; Zhang, J.; Luo, Y.; Zhang, P.; Zhang, Z.; Zhao, B. β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radical Biology and Medicine 2011, 50, 122-129. Wentzell, J.; Kretzschmar, D. Alzheimer's disease and tauopathy studies in flies and worms. Neurobiology of Disease 2010, 40, 21-28. Wu, Y.; Luo, Y. Transgenic C. elegans as a model in Alzheimer's research. Current Alzheimer Research 2005, 2, 37-45. Wu, Y.; Wu, Z.; Butko, P.; Christen, Y.; Lambert, M. P.; Klein, W. L.; Link, C. D.; Luo, Y. Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. Journal of Neuroscience 2006, 26, 13102-13113. Yatin, S.; Varadarajan, S.; Link, C.; Butterfield, D. In vitro and in vivo oxidative stress associated with Alzheimer’s amyloid -peptide (1–42). Neurobiology of Aging 1999, 20, 325-30. Yatin, S. M.; Varadarajan, S.; Butterfield, D. A. Vitamin E prevents Alzheimer's amyloid -peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. Journal of Alzheimer's Disease 2000, 2, 123-131. Zhang, T.; Hwang, H. Y.; Hao, H.; Talbot, C.; Wang, J. Caenorhabditis elegans RNA-processing protein TDP-1 regulates protein homeostasis and life span. Journal of Biological Chemistry 2012, 287, 8371-8382. Zheng, H.; Koo, E. H. The amyloid precursor protein: beyond amyloid. Molecular Neurodegeneration 2006, 1, 5. Zheng, J.; Greenway, F. L. Caenorhabditis elegans as a model for obesity research. International Journal of Obesity (Lond) 2012, 36, 186-94. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74891 | - |
dc.description.abstract | 阿茲海默症 (Alzheimer’s disease; AD) 為一程序性之神經退化疾病,主要症狀為記憶力下降、情緒失調與運動上之障礙等,造成全世界的健康隱憂。在普遍 AD 之患者腦部會發現類澱粉蛋白 (amyloid-β; Aβ) 堆積之現象,此一蛋白的不正常堆積不僅會造成神經細胞死亡,亦會促使腦部氧化壓力上升,故 Aβ的毒性 被視為造成 AD 主要原因之一。多甲氧基類黃酮 (Polymethoxy flavone; PMF) 為柑橘中含量豐富之機能性成分,在先前研究中顯示其具有許多生理功能,包括抗發炎、抗肥胖與神經保護之功效。然而,PMF 因溶解度差,並會降低其生物利用率。許多文獻指出,PMF 之水解產物 (Hydroxylated PMF; HPMF) 因具有較優良之溶解度,使其較 PMF 更具生理活性。故本篇研究想利用秀麗隱桿線蟲 (Caenorhabditis elegans) 做為評估阿茲海默症之模式生物,評估與比較 Tangeretin (Tan) 與水解型之 5, 4’-didemethyl tangeretin (DTan) 是否具降低氧化壓力與類澱粉蛋白堆積造成之毒性及其調控機制。研究結果顯示,Tan 與 DTan 於 100 μM皆能有效增加線蟲暴露氧化壓力劑 juglone 之存活率,進一步測量線蟲體內之活性氧物質 (ROS) 發現,與控制組相比,暴露 Tan 與 DTan 可顯著降低線蟲體內 ROS 含量約 20.16% 與 46.75%。評估 Tan 及 DTan 之抗 AD 活性,利用能表達人類 Aβ1-42 蛋白之轉機因品系線蟲 CL4176 與 CL2006。抗癱瘓試驗中發現,Tan 與 DTan 皆能有效延後轉基因線蟲 CL4176 與 CL2006 之癱瘓時間,於兩品系中 DTan 之半數致癱瘓時間皆較 Tan 長,推論 DTan 之抗 AD 活性較 Tan 優良。此外,發現暴露 Tan 與 DTan 之組別,CL4176 體內 ROS 含量皆有顯著降低約 18.10% 及 12.88 %。藉由西方墨點法定量 CL4176 中之 Aβ1-42 蛋白,暴露 Tan 及 DTan 皆能抑制 CL4176 中 Aβ1-42 蛋白之表現,然而,Tan 降低 Aβ1-42 蛋白卻優於 DTan;在 CL2006 線蟲 Aβ1-42 蛋白染色結果中發現,暴露 Tan 與 DTan 之組別皆能降低其體內 Aβ1-42 斑塊的堆積,而 DTan 之效果較 Tan 顯著。在暴露 Tan 及 DTan 後發現,皆能誘導轉錄因子 DAF-16/FOXO 轉移進細胞核內;並利用 RNA 干擾技術發現,Tan 與 DTan 延緩轉基因品系 CL4176 之抗 AD 效果與 DAF-16 之有關。由目前的研究結果可推論,Tan 及 DTan 具有降低氧化壓力與 Aβ 蛋白堆積所造成的毒性的能力,並推測為藉由 DAF-16/FOXO 所調控。本篇研究中雖無法進一步比較其優劣,但可推測 Tan 與 DTan 皆具有預防 AD 與氧化壓力相關疾病之潛能。 | zh_TW |
dc.description.abstract | Alzheimer’s disease (AD) is a progressive neurological disease characterized by deficits in memory, cognition, motor skills, and represents a major healthcare challenge worldwide. The aggregation of amyloid-β (Aβ) is known as the key hallmark in AD, and it causes cell death and oxidative stress in neurons. Polymethoxy flavone (PMF), such as tangeretin and nobiletin, is one of the most abundant bioactive compounds in the peel of citrus fruits. Increasing evidences showed that PMFs have many biological functions including anti-inflammatory, anti-obesity and neuroprotective effects. However, PMFs are difficult to dissolve in water, and hydroxylated PMFs (HPMFs) may solve this problem. This study investigated and compared the tangeretin (Tan) and 5,4’-didemethyl tangeretin (DTan) on reducing oxidative stress and Aβ-induced toxicity in Caenorhabditis elegans AD models, as long as underlying mechanisms. The results showed that both Tan and DTan increased the survival of C. elegans in juglone-induced oxidative stress. In addition, Tan and DTan attenuated endogenous levels of ROS in C. elegans by 20.16% and 46.75%, respectively. Moreover, both Tan and DTan significantly decreased time of the paralysis in transgenic strain CL4176 and CL2006 which express human Aβ1-42 protein in body wall muscle. Comparison of extension time of the paralysis, DTan was better than Tan. On the other hand, Tan and DTan attenuated endogenous levels of ROS in transgenic C. elegans by 18.10% and 12.88%, respectively. Furthermore, by using western blot and Aβ deposit staining assay, the results that Tan and DTan induced a decline in Aβ42 expression and deposits in transgenic strain CL4176 and CL2006. Finally, we showed that Tan and DTan affected the subcellular distribution of the FOXO transcription factor DAF-16. Otherwise, RNA interference by daf-16 showed that Tan and DTan affected on attenuating paralysis were absent in transgenic strain C. elegans CL4176. Current results from this study indicated that Tan and DTan significantly reduced oxidative stress and Aβ42-induced toxicity. Although we can’t compare the neuroprotective effect between Tan and DTan, but suggesting that Tan and DTan have potential for the prevention of AD-associated oxidative stress complications. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T09:09:40Z (GMT). No. of bitstreams: 1 ntu-108-R04641038-1.pdf: 3424291 bytes, checksum: 308cd779d728cb167651ef99d2d77cbc (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 謝誌(I)
摘要(II0) Abstract(IV) Graphic Abstract(VI) 目錄(VII) 附圖目錄(IX) 附表目錄(X) 圖目錄(XI) 表目錄(XII) `Abbreviation(XIII) 壹、研究動機(1) 貳、文獻回顧(2) 一、神經性退化疾病(2) (一) 失智症與阿茲海默症之進程(2) (二) 阿茲海默症之成因(4) (三) 類澱粉蛋白堆積與氧化壓力(8) (四) 降低阿茲海默症之進程(11) 二、多甲氧基類黃酮(12) (一) 柑橘類水果(12) (二) 柑橘類水果中之機能性成分(12) (三) 多甲氧基類黃酮(14) 三、秀麗隱桿線蟲與神經退化性疾病(14) (一) 秀麗隱桿線蟲之優勢(14) (二) C. elegans 與 AD(15) (三) Insulin/IGF-mediated signaling (IIS) 路徑(15) 參、實驗目的與架構(18) 一、實驗目的(18) 二、實驗架構與設計(19) (一) 實驗架構(19) (二) 實驗設計(19) 肆、材料與方法(20) 一、藥品試劑(20) 二、C. elegans 品系與培養條件(21) 三、實驗方法(22) (一) C. elegans 氧化壓力測試(22) (二) C. elegans 癱瘓試驗 (paralysis assay)(22) (三) 體內過氧化物質 (ROS) 定量試驗(23) (四) Aβ 蛋白螢光染色與定量(24) (五) 西方墨點法(25) (六) DAF-16 localization 試驗(27) (七) RNA干擾試驗 (RNA interference assay, RNAi)(27) (八) 統計分析(28) 伍、結果與討論(29) 一、分析 Tan 及 DTan 對於線蟲體內抗氧化能力。(29) (一) Tan 及 DTan 抑制 juglone 誘導之氧化壓力測試。(29) (二) Tan 及 DTan 降低體ROS含量(32) 二、分析 Tan 及 DTan 對於 C. elegans transgenic strain CL4176 抗阿茲海默症之能力。(34) (一) Tan 及 DTan 延緩 C. elegans transgenic strain CL4176 之癱瘓時間。(34) (二) Tan 及 DTan 降低 C. elegans transgenic strain CL4176體內之氧化壓力(37) (三) Tan 及 DTan 降低 C. elegans transgenic strain CL4176之 Aβ1-42 蛋白表現量(39) 三、分析 Tan 及 DTan 對於 C. elegans transgenic strain CL2006 抗阿茲海默症之能力(41) (一) Tan 及 DTan 延緩 C. elegans transgenic strain CL2006 之癱瘓時間(41) (二) Tan 及 DTan 降低 C. elegans transgenic strain CL2006 之 Aβ1-42 蛋白堆積。(45) 四、分析 Tan 及 DTan 減緩 Aβ1-42 蛋白造成毒性之分子機制。(48) (一) Tan 及 DTan 促使 DAF-16 translocation。(48) (二) Tan 及 DTan 減緩 Aβ1-42 蛋白造成毒性需要 DAF-16 的參與。(50) 陸、結論(54) 柒、參考文獻(55) | |
dc.language.iso | zh-TW | |
dc.title | 以秀麗隱桿線蟲探討 Tangeretin 及 Didemethyl-tangeretin 經由 DAF-16 降低氧化壓力與類澱粉蛋白造成之毒性 | zh_TW |
dc.title | Tangeretin and Didemethyl-tangeretin reduce oxidative stress and amyloid-β toxicity regulated by DAF-16 in
Caenorhabditis elegans | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-1 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 廖秀娟 | |
dc.contributor.oralexamcommittee | 何元順,羅翊禎 | |
dc.subject.keyword | 阿茲海默症,類澱粉蛋白,氧化壓力,多甲氧基類黃酮,秀麗隱桿線蟲,DAF-16, | zh_TW |
dc.subject.keyword | Alzheimer’s disease,Amyloid-β,Oxidative stress,Polymethoxy flavone,Caenorhabditis elegans,DAF-16, | en |
dc.relation.page | 65 | |
dc.identifier.doi | 10.6342/NTU201904172 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-10-14 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 3.34 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。